Cigarette smoke and dopaminergic system

Journal of Biochemical and Molecular Toxicology

Volumn 21, Issue 6, 2007, Pages 325-335

  Miller, Leah R ^a   Mukherjee, Shyamali ^a   Ansah, Twum A ^a   Das, Salil K ^a  

^a MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

Cigarette smoke exposure; Dopaminergic neuron system; Guinea pig; Locomotor activity; Neurobehavioral function

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER;

ANIMAL BEHAVIOR; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; LOCOMOTION; MALE; MESENCEPHALON; NONHUMAN; OXYGEN AFFINITY; RECEPTOR BINDING;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BRAIN; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; GUINEA PIGS; KINETICS; LIGANDS; MALE; MOTOR ACTIVITY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SMOKING;

CAVIA;

EID: 36749010667     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.20197     Document Type: Article

References (41)

1. Jarvik ME, Henningfield JE. Pharmacological treatment of tobacco dependence. Pharmacol Biochem Behav 1988;30:279-294.
2. Collins AC, Miner LL, Marks MK. Genetic influences on acute responses to nicotine and nicotinic tolerance in the mouse. Pharmacol Biochem Behav 1988;20:269-278.
3. Baron JA. Cigarette smoking and Parkinson's disease. Neurology 1996;36:1490-1496.
4. Baron JA. Beneficial effects of nicotine and cigarette smoking: The real, the possible and the spurious. Br Med Bull 1996;52(1):58-73.
5. Rosecrans JA. Effects of nicotine on behavioral arousal and brain 5-hydroxytryptamine function in female rats selected for differences in activity. Eur J Pharmacol 1971;14:29-37.
6. Battig K, Driscoll P, Schlatter J, Uster H. Effects of nicotine on the exploratory locomotion patterns of female Roman high- and low-avoidance rats. Pharmacol Biochem Behav 1976;4(4):435-439.
7. Cabib S, Bonaventura N. Parallel strain-dependent susceptibility to environmentally-induced stereotypic- and stress-induced behavioral sensitization in mice. Physiol Behav 1997;61(4):499-506.
8. Hatchell PC, Collins AC. Influences of genotype and sex on behavioral tolerance to nicotine in mice. Pharmacol Biochem Behav 1977;6(1):24-30.
9. Murphy N, Lam H, Maidment N. A comparison of morphine-induced locomotor activity and mesolimbic dopamine release in C57BL6, 129Sv, and DBA2 mice. J Neurochem 2001;79(3):626-635.
10. Janhunen S, Linnervuo A, Svensk M, Ahtee L. Effects of nicotine and epibatidine on locomotor activity and conditioned place preference in rats. Pharmacol Biochem Behav 2005;82:758-765.
11. Benwell MF, Balfour DF. The effects of acute and repeated nicotinic treatment on nucleus accumbens dopamine and locomotor activity. Br J Pharmacol 1992;105(4):849-856.
12. 2 dopamine receptors in mediating nicotine-induced hyperactivity in rats. Psychopharmacology (Berl) 1991;104(3):343-350.
13. Insel TR, Winslow J. Neurobiology of obsessive compulsive disorder. Psychiatr Clin North Am 1992;15(4):813-824.
14. Harvey BH, Stein DJ, Emsley RA. The new generation antipsychotics: Integrating the neuropathology and pharmacology of schizophrenia. S Afr Med J 1999;89:661-672.
15. Rauch SL, Savage CR. Neuroimaging and neuropsychology of the striatum. Bridging basic science and clinical practice. Psychiatr Clin North Am 1997;20(4):741-768.
16. Clarke PB, Hommer DW, Pert A, Skirboll LR. Electrophysiological actions of nicotine on substantia nigra single units. Br J Pharmacol 1985;85:827-835.
17. Janson AM, Fuxe K, Goldstein M. Differential effects of acute and chronic nicotine treatment of MPTP- (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced degeneration of nigrostriatal dopamine neurons in the black mouse. Clin Investig 1992;70:232-238.
18. Westfall TC, Fleming R, Fudger MF, Clark EG. Effect of nicotine and related substance upon amine levels in the brain. Ann NY Acad Sci 1967;142:83-100.
19. Dluzen DE, Anderson L. The effects of nicotine on dopamine and DOPAC output from rat striatal tissue. Eur J Pharm 1997;341:23-32.
20. Rahman S, Neugebauer N, Zhang Z, Crooks PA, Dwoskin LP, Bardo MT. The effects of a novel nicotinic receptor antagonist N,N-dodecane-1,12-diyl- bis-3-picolinium dibromide (bPiDDB) on acute and repeated nicotine-induced increases in extracellular dopamine in rat nucleus accumbens. Neuropharmacology 2006;52:755-763.
21. Akita M, Keiji I, Kuwahara M, Tsubone H. The daily pattern of heart rate, body temperature and locomotor activity in guinea pigs. Exp Anim 2001;50(5):409-415.
22. Mukherjee S, Woods L, Weston Z, Williams AB, Das SK. The effect of mainstream and sidestream cigarette smoke exposure on oxygen defense mechanisms of guinea pig erythrocytes. J Biochem Toxicology 1993;8(3):119-125.
23. Lowry CA, Renner KJ, Moor FL. Catecholamines and indoleamines in the central nervous system of a urodele amphibian: a microdissection study with emphasis on the distribution of epinephrine. Brain Behav Evol 1996;48:70-93.
24. Peterson GL. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 1977;83(2):346-356.
25. 1 receptor antagonist ligand, in rat striatum. Life Sci 1984;35(18):1885-1893.
26. Pugsley TA, Coughenour LL, Myers SL, Shih YH, Courtland GG, Berghoff W, Stewart SF. CI-943, a potential antipsychotic agent. II. Neurochemical effects. J Pharmacol Exp Therap 1989;251:113-122.
27. Akunne HC, Johannessen JN, DeCosta BR, Rice KC, Rotham RB. MPTP lesion of the nigrostriatal dopaminergic projection decrease [3H] 1-[1-(2-thienyl) cyclohexyl]piperdine binding to PCP site 2: further evidence that PCP site 2 is associated with the biogenic amine reuptake complex. Neurochem Res 1992;17:261-264.
28. Saunders CR, Das SK, Ramesh A, Shockley DC, Mukherjee S. Benzo(a)pyrene-induced acute neurotoxicity in F-344 rats: Role of oxidative stress. J Appl Toxicol 2006;26:427-438.
29. Clarke PB, Hommer DW, Pert A, Skirboll LR. Electrophysiological actions of nicotine on substantia nigra single units. Br J Pharmacol 1985;85:827-835.
30. Matsubayashi H, Inoue A, Amano T, Seki T, Nakata Y, Sasa M, Sakai N. Involvement of alpha-7- and alpha-4-beta-2 type postsynaptic nicotinic acetylcholine receptors in nicotine-induced excitation of dopaminergic neurons in the substantia nigra: a patch clamp and single-cell PCR study using acutely dissociated nigral neurons. Brain Res Mol Brain Res 2004;129(1/2):1-7.
31. Chang YL, Tsai P, Chou YC, Tien JH. Simultaneous determination of nicotine and its metabolite, cotinine, in rat blood and brain tissue using microdialysis coupled with liquid chromatography: pharmacokinetic application. J Chromatogr A 2005;1088(1/2):152-157.
32. Slotkin TA, Cho H, Whitmore WL. Effects of prenatal nicotine exposure on neuronal development: selective actions on central and peripheral catecholaminergic pathways. Brain Res Bull 1987;18(5):601-611.
33. Nisell M, Nomikos G, Hertel P, Panagis G, Svensson TH. Condition-independent sensitization of locomotor stimulation and mesocortical dopamine-release following chronic nicotine treatment in the rat. Synapse 1996;22(4):369-381.
34. Vihavainen T, Mijatovic J, Peipponen TP, Tuominen RK, Ahtee L. Effect of morphine on locomotor activity and striatal monoamine metabolism in nicotine-withdrawn mice. Behav Brain Res 2006;173(1):85-93.
35. Corrigall WA, Franklin KB, Coen KM, Clarke PB. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berl) 1992;107(2/3):285-289.
36. Louis M, Clarke PB. Effect of ventral tegmental 6-hydroxydopamine lesions on the locomotor stimulant action of nicotine in rats. Neuropharmacology 1998;37(12):1503-1513.
37. Tammimaki A, Pietila K, Raattamaa H, Ahtee L. Effect of quinpirole on striatal dopamine release and locomotor activity in nicotine-treated mice. Eur J Pharmacol 2006;531(1-3):118-125.
38. Haikala H. Different changes in striatal dopamine metabolism induced by nicotine in mice kept at different ambient temperatures. Evidence for partly separate metabolic routes of dopamine derived from separate compartmentations. Naunyn Schmiedebergs Arch Pharmacol 1986;334(4):373-376.
39. Grenhoff J, Svensson T. Selective stimulation of limbic dopamine activity by nicotine. Acta Physiol Scand 1988;133(4):595-596.
40. Horn AS. Dopamine uptake: a review of progress in the last decade. Prog Neurobiol 1990;34:387-400.
41. Gerfen CR, Engber TM. Molecular neuroanatomic mechanisms of Parkinson's disease: a proposed therapeutic approach. Neurol Clin 1992;10(2):435-439.